STXS stereotaxis.com Stock Quotes

Stereotaxis, Inc. (STXS) management is demonstrating flexibility within the robotic cardiac surgery segment, ensuring a transparent go-to-market strategy for Genesis. This chart's price trend confirms the asset's current valuation at 0.92. The company's growth relies on the development of arrhythmia therapy systems and the implementation of remote surgical control. A verified network of electronics and magnet suppliers guarantees assembly stability.

Stereotaxis, Inc. - STXS Share Price (period 07/04/2022 - 11/12/2026)

Analytical breakdowns and data insights for company Stereotaxis Inc (STXS)

- stock value and consensus price forecast:

Price Chart Stereotaxis, Inc.|STXS - Analyst Median Target

- market capitalization data:

Market Valuation Stereotaxis Inc|STXS - Aggregate Business Value

- issuer book value statistics:

Accounting Value per Share Stereotaxis|STXS - Accounting Capitalization|Market Value to Book Value Ratio stereotaxis.com|STXS - Company Total Asset Base

- debt and solvency information:

- financial results and valuation multiples details:

STXS - Net Financial Result|Projected Future Earnings Stereotaxis, Inc.|STXS - P/E Multiple|Future Price to Earnings Stereotaxis|STXS - Price/Earnings to Growth Ratio|EV/EBITDA Multiple Stereotaxis Inc|STXS - Operating income before deduction of amortization|Net earnings per share for the last 12 months Stereotaxis|STXS - Earnings per one share for the last 12 months|Quarterly EPS earnings growth stereotaxis.com|STXS - Earnings per share growth rate in current year|Earnings growth forecast for next year Stereotaxis, Inc.

Fundamental company valuation:Stereotaxis, Inc.

Stereotaxis, Inc. (STXS) maintains a dominant position in the robotic cardiac surgery segment due to unique patents and high barriers to entry for competitors. Analyzing the historical stock prices on GURU.Markets, an investor sees the current value of 0.92, which reflects the daily market value of the business share, allowing for an assessment of the real volatility and the long-term capitalization vector of this high-tech asset.

Competitors of Stereotaxis, Inc. (STXS)